BCL2L2 | OmnibusX

Name	Number of supported studies	Average coverage
epithelial cell	3 studies	21% ± 2%	Explore

sc-RNAseq data

Insufficient scRNA-seq data for expression of BCL2L2 at tissue level.

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	8869.36	1445 / 1445	100%	26.61	183 / 183
prostate	100%	7178.10	245 / 245	100%	66.98	502 / 502
breast	100%	5422.18	459 / 459	99%	35.45	1112 / 1118
brain	100%	9509.92	2642 / 2642	99%	50.04	701 / 705
intestine	100%	9209.31	966 / 966	99%	24.82	522 / 527
thymus	100%	5281.51	652 / 653	99%	42.67	600 / 605
stomach	100%	6081.59	359 / 359	99%	21.51	282 / 286
pancreas	100%	4093.99	327 / 328	99%	38.95	176 / 178
lung	99%	5289.00	575 / 578	99%	30.80	1141 / 1155
adrenal gland	100%	5051.29	258 / 258	98%	50.26	226 / 230
uterus	100%	5790.12	170 / 170	98%	33.88	450 / 459
bladder	100%	8210.43	21 / 21	98%	26.84	492 / 504
skin	100%	5271.10	1809 / 1809	97%	33.09	458 / 472
kidney	100%	4487.02	89 / 89	97%	30.23	873 / 901
ovary	100%	4322.81	180 / 180	95%	16.56	408 / 430
liver	80%	1397.62	181 / 226	73%	10.37	298 / 406
adipose	100%	5583.24	1204 / 1204	0%	0	0 / 0
blood vessel	100%	7808.06	1335 / 1335	0%	0	0 / 0
spleen	100%	3082.39	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	36.97	45 / 45
eye	0%	0	0 / 0	98%	32.18	78 / 80
heart	96%	3652.47	830 / 861	0%	0	0 / 0
muscle	89%	1986.55	714 / 803	0%	0	0 / 0
lymph node	0%	0	0 / 0	72%	9.15	21 / 29
peripheral blood	19%	477.81	172 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

GO_0006919	Biological process	activation of cysteine-type endopeptidase activity involved in apoptotic process
GO_0007283	Biological process	spermatogenesis
GO_0002931	Biological process	response to ischemia
GO_0090201	Biological process	negative regulation of release of cytochrome c from mitochondria
GO_0071392	Biological process	cellular response to estradiol stimulus
GO_1905430	Biological process	cellular response to glycine
GO_0060011	Biological process	Sertoli cell proliferation
GO_0042981	Biological process	regulation of apoptotic process
GO_0043066	Biological process	negative regulation of apoptotic process
GO_0097192	Biological process	extrinsic apoptotic signaling pathway in absence of ligand
GO_0008630	Biological process	intrinsic apoptotic signaling pathway in response to DNA damage
GO_0001836	Biological process	release of cytochrome c from mitochondria
GO_0035795	Biological process	negative regulation of mitochondrial membrane permeability
GO_1904646	Biological process	cellular response to amyloid-beta
GO_0005829	Cellular component	cytosol
GO_0005741	Cellular component	mitochondrial outer membrane
GO_0097136	Cellular component	Bcl-2 family protein complex
GO_0044877	Molecular function	protein-containing complex binding
GO_0042802	Molecular function	identical protein binding
GO_0051400	Molecular function	BH domain binding
GO_0097718	Molecular function	disordered domain specific binding
GO_0005515	Molecular function	protein binding

Gene name	BCL2L2
Protein name	BCL2 like 2 Bcl-2-like protein 2 (Bcl2-L-2) (Apoptosis regulator Bcl-W)
Synonyms	KIAA0271 BCLW
Description	FUNCTION: Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX. .
Accessions	G3V4B7 G3V3G8 Q92843 ENST00000679000.1 [Q92843-1] ENST00000250405.10 [Q92843-1] ENST00000678311.1 [Q92843-1] ENST00000557236.6 ENST00000556100.3 [Q92843-1] H0YJC7 ENST00000553824.5 ENST00000556599.1 ENST00000557008.2 [Q92843-2] ENST00000554635.1 G3V3B7 ENST00000553781.5 [Q92843-2] G3V5A9 ENST00000679219.1 [Q92843-1] ENST00000557579.2

BCL2L2 report